A study conducted at Sheba Medical Center indicates a fourth shot of the Pfizer coronavirus vaccine provides insufficient protection against the Omicron variant of the virus.
The data appears to raise serious questions regarding Israel’s current strategy of boosting all people over the age of 60.
Prof. Gili Regev-Yochay, a top infectious disease expert at the hospital, says the results of the research are only preliminary, but acknowledges there is high public interest in the matter.
“We see an increase in antibodies, higher than after the third dose,” she says. “However, we see many infected with Omicron who received the fourth dose. Granted, a bit less than in the control group, but still a lot of infections.”
Data from the study was not immediately available.
Regev-Yochay says “the bottom line is that the vaccine is excellent against the Alpha and Delta [variants], for Omicron it’s not good enough.”
She still says it is probably a good idea to give a fourth shot to those at higher risk, but that perhaps the current recommendations should be changed to only include older groups.
Watch Docu Nation Season 2: Resilience
when you join the ToI Community
Support The Times of Israel's independent journalism and receive access to our documentary series, Docu Nation: Resilience, premiering December 12.
In this season of Docu Nation, you can stream eight outstanding Israeli documentaries with English subtitles and then join a live online discussion with the filmmakers. The selected films show how resilience, hope, and growth can emerge from crisis.
When you watch Docu Nation, you’re also supporting Israeli creators at a time when it’s increasingly difficult for them to share their work globally.
To learn more about Docu Nation: Resilience, click here.
Support ToI and get Docu Nation
Support ToI and get Docu Nation
Already a member? Sign in to stop seeing this
You're a dedicated reader
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel eleven years ago - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you,
David Horovitz, Founding Editor of The Times of Israel
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this